{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T11:13:02Z","timestamp":1759230782550,"version":"3.44.0"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Candidemia is associated with high morbidity and mortality. Delayed initiation of effective and appropriate antifungal therapy correlates with increased patient mortality, emphasizing the importance of rapid antifungal susceptibility testing (AFST). Usual commercial methods, such as the standard E-test, are time-consuming, often requiring a minimum of 48 h. This study aimed to evaluate the performance of direct E-test (ET-dir) directly from positive blood culture bottles, with the goal of reducing turnaround time and improving clinical decision-making. A total of 160 yeast positive blood cultures were included over a 4-year period, comprising 85 Candida albicans. The minimum inhibitory concentrations (MICs) of fluconazole, voriconazole, amphotericin B, and anidulafungin were determined using ET-dir and compared to ET method (ET-sd). Essential agreement, categorical agreement, error rates, and bias were analyzed for all species and specifically for C. albicans. The essential agreement between ET-dir and ET-sd exceeded 87% for all antifungal agents and reached\u00a0\u226590% for fluconazole. The categorical agreement was above 90% for all agents, and error rates remained within acceptable limits except for anidulafungin. For C. albicans, 23 of 24 performance data met acceptability criteria, with essential agreement\u00a0\u226590% for all agents except fluconazole. ET-dir results were interpretable within 24 h for 93.7% of strains, providing at least a 24-h time gain over ET-sd. ET-dir is a reliable and rapid AFST method for candidemia, meeting most performance criteria compared to ET-sd while significantly reducing turnaround time. Its routine implementation could enable faster adaptation of antifungal therapy, ensuring that treatments are optimized based on susceptibility results.<\/jats:p>","DOI":"10.1093\/mmy\/myaf077","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T15:36:09Z","timestamp":1755963369000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of direct antifungal susceptibility testing using E-test for four antifungal agents in candidemia patients"],"prefix":"10.1093","volume":"63","author":[{"given":"Gr\u00e9goire","family":"Miaux","sequence":"first","affiliation":[{"name":"Centre Hospitalier de Valenciennes Microbiology Department, , Valenciennes ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryane","family":"Benkhelil","sequence":"additional","affiliation":[{"name":"Centre Hospitalier de Valenciennes Microbiology Department, , Valenciennes ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gis\u00e8le","family":"Dewulf","sequence":"additional","affiliation":[{"name":"Centre Hospitalier de Valenciennes Microbiology Department, , Valenciennes ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9verine","family":"Loridant","sequence":"additional","affiliation":[{"name":"Univ. Lille, Inserm U1285, CHU Lille, Laboratoire Parasitologie-Mycologie, CNRS, UMR 8576 - UGSF \u2013 Unit\u00e9 de Glycobiologie Structurale et Fonctionnelle , Lille ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2817-3830","authenticated-orcid":false,"given":"Eric","family":"Dannaoui","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Paris-Cit\u00e9 University , Paris ,","place":["France"]},{"name":"APHP, Necker Enfants-Malades Hospital, Parasitology-Mycology Unit Microbiology Department, , Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1555-804X","authenticated-orcid":false,"given":"Edith","family":"Mazars","sequence":"additional","affiliation":[{"name":"Centre Hospitalier de Valenciennes Microbiology Department, , Valenciennes ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,8,23]]},"reference":[{"issue":"15","key":"2025093006564630400_bib1","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1056\/NEJMra1315399","article-title":"Invasive candidiasis","volume":"373","author":"Kullberg","year":"2015","journal-title":"N Engl J Med"},{"volume-title":"WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action","year":"2022","author":"World Health Organization (WHO)","key":"2025093006564630400_bib2"},{"issue":"7","key":"2025093006564630400_bib3","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"2025093006564630400_bib4","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.cmi.2019.04.024","article-title":"Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis","volume":"25","author":"Koehler","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"2025093006564630400_bib5","doi-asserted-by":"crossref","first-page":"003","DOI":"10.1055\/s-0040-1701215","volume":"41","author":"Gonzalez-Lara","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"issue":"25","key":"2025093006564630400_bib6","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis","volume":"347","author":"Mora-Duarte","year":"2002","journal-title":"N Engl J Med"},{"issue":"5","key":"2025093006564630400_bib7","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/376906","article-title":"A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients","volume":"37","author":"Pappas","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"9","key":"2025093006564630400_bib8","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1086\/378745","article-title":"Attributable mortality of nosocomial candidemia, revisited","volume":"37","author":"Gudlaugsson","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"12","key":"2025093006564630400_bib9","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.medmal.2009.02.008","article-title":"\u00c9pid\u00e9miologie des candid\u00e9mies: \u00e9tude observationnelle prospective d'un an dans l'Ouest de la France","volume":"39","author":"Talarmin","year":"2009","journal-title":"Med Mal Infect"},{"issue":"4","key":"2025093006564630400_bib10","doi-asserted-by":"publisher","first-page":"O245","DOI":"10.1111\/1469-0691.12380","article-title":"Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain","volume":"20","author":"Puig-Asensio","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"2025093006564630400_bib11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s15010-020-01393-9","article-title":"Epidemiology of candidemia and impact of infectious disease consultation on survival and care","volume":"48","author":"Mohr","year":"2020","journal-title":"Infection"},{"issue":"12","key":"2025093006564630400_bib12","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1128\/JCM.43.12.5848-5859.2005","article-title":"Results from the ARTEMIS DISK global antifungal surveillance study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing","volume":"43","author":"Pfaller","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"9","key":"2025093006564630400_bib13","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","article-title":"Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality","volume":"49","author":"Morrell","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2025093006564630400_bib14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1086\/504810","article-title":"Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study","volume":"43","author":"Garey","year":"2006","journal-title":"Clin Infect Dis"},{"volume-title":"M27 Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts","year":"2017","author":"Clinical and Laboratory Standards Institute (CLSI)","key":"2025093006564630400_bib15"},{"article-title":"Clinical breakpoints for fungi v. 10.0","year":"2020","author":"EUCAST","key":"2025093006564630400_bib16"},{"author":"EUCAST","key":"2025093006564630400_bib17","article-title":"Interpretation of MICs for rare yeast without breakpoints in breakpoint tables"},{"issue":"10","key":"2025093006564630400_bib18","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1128\/JCM.38.10.3715-3717.2000","article-title":"Evaluation of the etest method for determining voriconazole susceptibilities of 312 clinical isolates of Candida species by using three different agar Media","volume":"38","author":"Pfaller","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"5","key":"2025093006564630400_bib19","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/jac\/47.5.521","article-title":"Comparison of Etest and a tablet diffusion test with the NCCLS broth microdilution method for fluconazole and amphotericin B susceptibility testing of Candida isolates","volume":"47","author":"Arendrup","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"2025093006564630400_bib20","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1128\/JCM.39.12.4387-4389.2001","article-title":"Evaluation of Etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida species","volume":"39","author":"Pfaller","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"6","key":"2025093006564630400_bib21","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1128\/AAC.46.6.1781-1784.2002","article-title":"Precision and accuracy of fluconazole susceptibility testing by broth microdilution, etest, and disk diffusion methods","volume":"46","author":"Barry","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"2025093006564630400_bib22","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/j.1469-0691.2005.01166.x","article-title":"Correlation between the procedure for antifungal susceptibility testing for Candida spp. of the European Committee on Antibiotic Susceptibility Testing (EUCAST) and four commercial techniques","volume":"11","author":"Cuenca-Estrella","year":"2005","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"2025093006564630400_bib23","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1128\/JCM.01840-06","article-title":"Comparative evaluation of etest and sensititre YeastOne panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents","volume":"45","author":"Alexander","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"5","key":"2025093006564630400_bib24","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1128\/JCM.02445-09","article-title":"Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and etest methods with the CLSI Broth microdilution method for echinocandin susceptibility testing of Candida species","volume":"48","author":"Pfaller","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"4","key":"2025093006564630400_bib25","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1128\/JCM.39.4.1328-1333.2001","article-title":"Evaluation of etest for direct antifungal susceptibility testing of yeasts in positive blood cultures","volume":"39","author":"Chang","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"4","key":"2025093006564630400_bib26","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1128\/JCM.43.4.1727-1731.2005","article-title":"CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures","volume":"43","author":"Tan","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"6","key":"2025093006564630400_bib27","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1128\/JCM.02321-09","article-title":"Rapid antifungal susceptibility determination for yeast isolates by use of etest performed directly on blood samples from patients with fungemia","volume":"48","author":"Guinea","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"12","key":"2025093006564630400_bib28","doi-asserted-by":"publisher","first-page":"e114834","DOI":"10.1371\/journal.pone.0114834","article-title":"Rapid identification and susceptibility testing of Candida spp. from positive blood cultures by combination of direct MALDI-TOF mass spectrometry and direct inoculation of Vitek 2","volume":"9","author":"Idelevich","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"2025093006564630400_bib29","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1128\/JCM.02432-15","article-title":"Agreement of direct antifungal susceptibility testing from positive blood culture bottles with the conventional method for Candida species","volume":"54","author":"Jabeen","year":"2016","journal-title":"J Clin Microbiol"},{"issue":"7","key":"2025093006564630400_bib30","doi-asserted-by":"publisher","first-page":"e00400","DOI":"10.1128\/AAC.00400-17","article-title":"The etest performed directly on blood culture bottles is a reliable tool for detection of fluconazole-resistant Candida albicans isolates","volume":"61","author":"Escribano","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2025093006564630400_bib31","doi-asserted-by":"publisher","first-page":"e22297","DOI":"10.1002\/jcla.22297","article-title":"Evaluation of direct antifungal susceptibility testing methods of Candida spp. from positive blood culture bottles","volume":"32","author":"Oz","year":"2018","journal-title":"J Clin Lab Anal"},{"key":"2025093006564630400_bib32","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.3389\/fmicb.2018.02400","article-title":"A rapid procedure for identification and antifungal susceptibility testing of yeasts from positive blood cultures","volume":"9","author":"Vecchione","year":"2018","journal-title":"Front Microbiol"},{"key":"2025093006564630400_bib33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fcimb.2019.00020","article-title":"Candida auris identification and rapid antifungal susceptibility testing against echinocandins by MALDI-TOF MS","volume":"9","author":"Vatanshenassan","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"2025093006564630400_bib34","doi-asserted-by":"publisher","first-page":"e00311","DOI":"10.1128\/JCM.00311-21","article-title":"Direct fluconazole disk susceptibility testing for Candida glabrata-positive blood cultures","volume":"59","author":"Israel","year":"2021","journal-title":"J Clin Microbiol"},{"article-title":"Recommandations","year":"2024","author":"Comit\u00e9 de l'antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie (CASFM)","key":"2025093006564630400_bib35"},{"article-title":"Methodology - rapid antimicrobial susceptibility testing (RAST) directly from positive blood culture bottles","year":"2024","author":"EUCAST","key":"2025093006564630400_bib36"},{"article-title":"Recommandations","year":"2018","author":"CASFM","key":"2025093006564630400_bib37"},{"issue":"11","key":"2025093006564630400_bib38","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1093\/jac\/dkaa333","article-title":"EUCAST rapid antimicrobial susceptibility testing (RAST) in blood cultures: validation in 55 European laboratories","volume":"75","author":"\u00c5kerlund","year":"2020","journal-title":"J Antimicrob Chemother"},{"article-title":"Package Insert - 9305056. D - en - Etest - AFST WW","year":"2013","author":"BioM\u00e9rieux","key":"2025093006564630400_bib39"},{"article-title":"ISO 20776 partie 1\u202f: m\u00e9thode de r\u00e9f\u00e9rence de microdilution en bouillon pour la d\u00e9termination de la sensibilit\u00e9 in vitro aux agents antimicrobiens des bact\u00e9ries a\u00e9robies \u00e0 croissance rapide impliqu\u00e9es dans les maladies infectieuses","year":"2019","author":"Organisation internationale de normalisation (ISO)","key":"2025093006564630400_bib40"},{"article-title":"Antimicrobial susceptibility test (AST) systems - class II special controls guidance for industry and FDA","year":"2018","author":"Food and Drug Administration (FDA). Health C for D and R","key":"2025093006564630400_bib41"},{"issue":"4","key":"2025093006564630400_bib42","doi-asserted-by":"publisher","first-page":"e01934","DOI":"10.1128\/JCM.01934-17","article-title":"CLSI methods development and standardization working Group Best practices for evaluation of antimicrobial susceptibility tests","volume":"56","author":"Humphries","year":"2018","journal-title":"J Clin Microbiol"},{"article-title":"ISO 20776 partie 2: \u00e9valuation des performances des dispositifs pour antibiogrammes par rapport \u00e0 une m\u00e9thode de r\u00e9f\u00e9rence de microdilution en bouillon","year":"2021","author":"Organisation internationale de normalisation (ISO)","key":"2025093006564630400_bib43"},{"issue":"4","key":"2025093006564630400_bib44","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0732-8893(94)90034-5","article-title":"Etest for antifungal susceptibility testing of yeasts","volume":"19","author":"Espinel-Ingroff","year":"1994","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"7","key":"2025093006564630400_bib45","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1128\/JCM.00053-08","article-title":"Detection of caspofungin resistance in Candida spp. by Etest","volume":"46","author":"Desnos-Ollivier","year":"2008","journal-title":"J. Clin. Microbiol."},{"issue":"4","key":"2025093006564630400_bib46","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/jof5040108","article-title":"Antifungal susceptibly testing by concentration gradient strip Etest method for fungal isolates: a review","volume":"5","author":"Dannaoui","year":"2019","journal-title":"J Fungi"},{"issue":"3","key":"2025093006564630400_bib47","doi-asserted-by":"publisher","first-page":"e00069","DOI":"10.1128\/CMR.00069-19","article-title":"Antifungal susceptibility testing: current approaches","volume":"33","author":"Berkow","year":"2020","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"2025093006564630400_bib48","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3390\/jof8030309","article-title":"Commercial methods for antifungal susceptibility testing of yeasts: strengths and limitations as predictors of resistance","volume":"8","author":"Espinel-Ingroff","year":"2022","journal-title":"J Fungi"},{"issue":"2","key":"2025093006564630400_bib49","doi-asserted-by":"publisher","first-page":"100970","DOI":"10.1016\/j.mycmed.2020.100970","article-title":"Antifungal susceptibility testing practices in mycology laboratories in France","volume":"30","author":"Bellanger","year":"2020","journal-title":"J Mycol Med"},{"issue":"5","key":"2025093006564630400_bib50","doi-asserted-by":"publisher","first-page":"652.e9","DOI":"10.1016\/j.cmi.2022.11.030","article-title":"Gradient concentration strip-specific epidemiological cut-off values of antifungal drugs in various yeast species and five prevalent Aspergillus species complexes","volume":"29","author":"Mercier","year":"2023","journal-title":"Clin Microbiol Infect"},{"author":"Liofilchem\u00ae","key":"2025093006564630400_bib51","article-title":"Liofilchem MIC test strip"},{"issue":"1","key":"2025093006564630400_bib52","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/jof7010063","article-title":"Rapid antifungal susceptibility testing of yeasts and molds by MALDI-TOF MS: a systematic review and meta-analysis","volume":"7","author":"Knoll","year":"2021","journal-title":"J Fungi"},{"issue":"3","key":"2025093006564630400_bib53","doi-asserted-by":"publisher","first-page":"115950","DOI":"10.1016\/j.diagmicrobio.2023.115950","article-title":"Multicenter evaluation of rapid antimicrobial susceptibility testing by VITEK\u00ae2 directly from positive blood culture","volume":"106","author":"Paluch","year":"2023","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"2025093006564630400_bib54","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/jac\/dkz548","article-title":"The EUCAST rapid disc diffusion method for antimicrobial susceptibility testing directly from positive blood culture bottles","volume":"75","author":"Jonasson","year":"2020","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"2025093006564630400_bib55","doi-asserted-by":"publisher","first-page":"116271","DOI":"10.1016\/j.diagmicrobio.2024.116271","article-title":"Rapid identification,fluconazole and micafungin susceptibility testing of Candida species from blood culture by a short incubation method","volume":"109","author":"De\u00a0Souza","year":"2024","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myaf077\/64114379\/myaf077.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/63\/10\/myaf077\/64114379\/myaf077.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/63\/10\/myaf077\/64114379\/myaf077.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:56:55Z","timestamp":1759229815000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myaf077\/8240246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,23]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,9,30]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myaf077","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"type":"print","value":"1369-3786"},{"type":"electronic","value":"1460-2709"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,8,23]]},"article-number":"myaf077"}}